Overview of Recent Advances in Canine Parvovirus Research: Current Status and Future Perspectives
文献类型: 外文期刊
作者: Zhou, Hongzhuan 1 ; Cui, Kaidi 1 ; Su, Xia 1 ; Zhang, Huanhuan 1 ; Xiao, Bing 1 ; Li, Songping 1 ; Yang, Bing 1 ;
作者机构: 1.Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Lives, Beijing 100097, Peoples R China
2.Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 117004, Peoples R China
关键词: canine parvovirus; research advances; pathogenesis; antiviral drugs
期刊名称:MICROORGANISMS ( 影响因子:4.2; 五年影响因子:4.6 )
ISSN:
年卷期: 2025 年 13 卷 1 期
页码:
收录情况: SCI
摘要: Canine parvovirus (CPV-2) was first identified in the late 1970s and has since become one of the most significant infectious agents affecting dogs. CPV-2 causes severe diseases such as hemorrhagic gastroenteritis and myocarditis, posing a major threat to canine health, particularly with a high mortality rate in puppies. It is globally recognized as a highly contagious and lethal pathogen. CPV is prone to rapid mutation, leading to the emergence of new variants. Despite widespread vaccination efforts, CPV remains one of the primary causes of acute gastroenteritis and death in young and juvenile dogs. Furthermore, the detection of CPV in swine populations has introduced additional challenges to its control. This review summarizes the current epidemiological status of CPV, highlighting recent advancements in diagnostic techniques and vaccine development. Additionally, it discusses the latest research on the pathogenesis of the virus and the development of antiviral agent research and proposes prevention and control suggestions for CPV under the One Health concept. In particular, there is a need to enhance surveillance of viral dynamics, accelerate the development of novel vaccines, and deepen the exploration of the underlying pathogenic mechanisms. This review aims to provide a scientific foundation for effective control of CPV and to guide future research directions.
- 相关文献
作者其他论文 更多>>
-
Identification of Host-Protein Interaction Network of Canine Parvovirus Capsid Protein VP2 in F81 Cells
作者:Zhou, Hongzhuan;Zhang, Huanhuan;Su, Xia;Xu, Fuzhou;Xiao, Bing;Zhang, Jin;Qi, Qi;Lin, Lulu;Cui, Kaidi;Li, Qinqin;Li, Songping;Yang, Bing;Zhang, Huanhuan;Cui, Kaidi;Li, Qinqin;Li, Songping
关键词:CPV; VP2; protein interaction network; FHL2
-
Transcriptional Differential Analysis of Nitazoxanide-Mediated Anticanine Parvovirus Effect in F81 Cells
作者:Su, Xia;Zhou, Hongzhuan;Han, Ziwei;Xu, Fuzhou;Xiao, Bing;Zhang, Jin;Qi, Qi;Lin, Lulu;Zhang, Huanhuan;Li, Songping;Yang, Bing;Han, Ziwei;Zhang, Huanhuan;Li, Songping
关键词:canine parvovirus; nitazoxanide; RNA-seq; cell cycle
-
Chaperonin TRiC/CCT subunit CCT7 is involved in the replication of canine parvovirus in F81 cells
作者:Su, Xia;Zhou, Hongzhuan;Xu, Fuzhou;Zhang, Jin;Xiao, Bing;Qi, Qi;Lin, Lulu;Yang, Bing
关键词:canine parvovirus; CCT7; VP2; replication; stability
-
Assessment of probiotic Bacillus velezensis supplementation to reduce Campylobacter jejuni colonization in chickens
作者:Cui, Yifang;Li, Pengxiang;Guo, Fangfang;Yang, Bing;Su, Xia;Zhou, Hongzhuan;Xu, Fuzhou;Zhu, Jiajia;Zhu, Kui
关键词:probiotic; Bacillus velezensis; antimicrobial activity; Campylobacter jejuni; chicken
-
Ct value-based real time PCR serotyping of Glaesserella parasuis
作者:Cui, Yifang;Guo, Fangfang;Cao, Xiaoya;Guo, Jie;Wang, Hongjun;Yang, Bing;Zhou, Hongzhuan;Su, Xia;Xu, Fuzhou;Cai, Xuwang;Blackall, Patrick J.
关键词:Glaesserella parasuis; Molecular serotyping; Real time PCR; Cycle threshold
-
Immunization of Chickens with the Enterobactin Conjugate Vaccine Reduced Campylobacter jejuni Colonization in the Intestine
作者:Cui, Yifang;Guo, Fangfang;Guo, Jie;Cao, Xiaoya;Yang, Bing;Zhou, Hongzhuan;Su, Xia;Xu, Fuzhou;Wang, Huiwen;Zeng, Ximin;Lin, Jun
关键词:enterobactin; conjugate vaccine; Campylobacter jejuni; chicken; colonization
-
Inhibitory Effects of Antiviral Drug Candidates on Canine Parvovirus in F81 cells
作者:Zhou, Hongzhuan;Su, Xia;Lin, Lulu;Zhang, Jin;Qi, Qi;Guo, Fangfang;Xu, Fuzhou;Yang, Bing
关键词:canine parvovirus; FDA-approved drug library; antiviral inhibitors; cytopathic effect (CPE)-based high-throughput screening assay



